McDermott and Bull executive Search
 

Other News

Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021

– Sales of $10.7 billion, including $2.4 billion of COVID-19 diagnostic testing-related sales – Sales growth of 28.7 percent; organic sales growth of 28.4 percent – GAAP diluted EPS from continuing operations growth of 103.4 percent; adjusted diluted EPS growth of 52.6 percent – Delivered more than 300 million COVID-19 […]

FLEX Vessel Prep™ System Data Presented During Leipzig Interventional Course (LINC) 2021

Trio of studies demonstrate that FLEX Vessel Prep System safely and effectively modifies obstructive plaque to facilitate delivery of definitive therapies MINNEAPOLIS, Jan. 27, 2021 /PRNewswire/ — VentureMed Group, Inc. (VentureMed), a privately-held medical device innovator, announced today that data from three studies evaluating the use of its FLEX Vessel Prep (VP) System were […]

Valcare Medical Announces First-in-Human Transseptal Implant of the AMEND™ Annuloplasty Ring for Mitral Valve Repair

HERZLIYA, Israel, Jan. 27, 2021 /PRNewswire/ — Valcare Medical Ltd. developer of transcatheter mitral and tricuspid valve repair and replacement solutions, announces that it has successfully completed its first-in-human transseptal delivery of the AMEND™ annuloplasty ring. The transseptal AMEND procedure was performed at the Schulich Heart Centre at Sunnybrook Health Sciences Centre in Toronto, under […]

Philips integrates 3D ultrasound with innovative software for breakthrough in surveillance of abdominal aortic aneurysms

Philips Abdominal Aortic Aneurysm (AAA) Model helps increase diagnostic confidence and improved patient experience compared to current standard of care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has introduced the Philips Abdominal Aortic Aneurysm (AAA) Model, providing physicians a more patient-friendly solution compared to […]

Microbot Medical Announces Successful Outcome of its Discussions with FDA Regarding Regulation of Self-Cleaning Shunt

FDA Feedback Reflects Strength of Pre-Clinical Safety Data; Maintains Q3 2022 Projected Commencement of First-in-Human Clinical Trial HINGHAM, Mass., Jan. 27, 2021 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced the completion of successful discussions with the U.S. Food and Drug Administration (FDA) for its Self-Cleaning Shunt (SCS). After review […]

Elixir Medical Announces Outstanding 24-month Data for DynamX Coronary Bioadaptor System, Demonstrating Strong Safety With No Target Lesion Revascularization, Myocardial Infarction or Thrombosis Through 24 Months

Successful DynamX Bioadaptor Live Case Presented at Singapore Live MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced the 24-month clinical results for the DynamX™ Coronary Bioadaptor System, the first drug-eluting coronary artery implant that adapts to vessel physiology. The results were presented at the 30th Annual Live […]

ZOLL Foundation Grants to Nearly 70 Recipients in Resuscitation and Critical Care Research Surpass $2.5 Million

15 Grantees Awarded Nearly $500,000 in Final 2020 Application Round CHELMSFORD, Mass.–(BUSINESS WIRE)–In the application round ended September 30, 2020, the ZOLL Foundation, established in 2014 to support young investigators through research grants in the fields of resuscitation and acute critical care, received 35 applications from across the United States, […]

Foldax Biopolymer Shown to Possess Ideal Properties for Heart Valve in New Published Paper

Company’s LifePolymer Material Used in First Polymer Heart Valves Ever Approved by FDA for Use in Clinical Trials SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced publication of a research paper in Advanced NanoBiomed Research that concluded that its LifePolymer™ biopolymer “exhibits ideal biomaterial properties for the flexible leaflets of a totally synthetic […]